Stay updated on Elranatamab Combo in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study locations list was updated: Changchun, Jilin, China was added and Ostrava, Czechia was removed, changing the total number of locations to 85. The page also adds a glossary toggle and updates the revision to v3.4.0.
    Difference
    0.9%
    Check dated 2026-01-28T06:27:55.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added MagnetisMM-6 study details with full title, design, interventions, outcomes, start/completion dates, enrollment, and 86 locations. Deleted the previous MagnetisMM-6 entry describing the older study version.
    Difference
    1%
    Check dated 2026-01-14T03:25:27.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now includes related topics: Multiple myeloma and MedlinePlus Genetics. This is a minor addition to related topics and does not affect core study information; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-30T22:57:55.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added 85 recruitment locations across multiple countries, expanding where patients can enroll.
    Difference
    4%
    Check dated 2025-12-23T21:22:02.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the page.
    Difference
    0.1%
    Check dated 2025-12-16T19:59:45.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Deleted references to "Multiple myeloma" and related topics ("MedlinePlus Genetics") from the Study Details page.
    Difference
    0.1%
    Check dated 2025-12-09T15:31:03.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.